Pall T. Onundarson: Fiix-Monitored Warfarin is Actually More Effective than Unmonitored DOACs!
Pall T. Onundarson, Professor Emeritus at Landspitali University Hospital, recently shared an insightful post on LinkedIn:
”Convenient DOAC drugs have been forced to replace conventional PT-INR monitored VKAs to a large degree in patients with AF and VTE while conventional PT-INR monitored VKAs remains used for other conditions where VKAs have been shown to be more effective or safer. Observational data from Germany and the UK suggest lower mortality in VKA treated AF patients.
Would it change the scenario if the effectiveness of VKAs could be enhanced by using a more modern monitoring method than the PT-INR? How would that influence prescriptions?
For patients needing VKAs such as warfarin, isn´t it amazing that most of the world continues to use an old suboptimal test (PT-INR) to monitor and dose them when a better method exists?
There are only historical reasons for using the old Quick-PT or the Owren´s PT to calculate a normalized ratio; these tests were developed prior to full understanding of coagulation and the antithrombotic effect of VKAs.
Do suboptimal tests cause erroneous tailoring of the dose and consequent suboptimal outcomes? Our 3 clinical studies have found better patient outcomes with Fiix (factor II and X only) monitored warfarin than with conventional PT-monitored warfarin – and suggestive evidence that Fiix-monitored warfarin is actually more effective than unmonitored DOAC drugs in non-valvular atrial fibrillation patients.
These data showing more effective and more convenient warfarin management using Fiix monitoring appears not to interest many. In particular not cardiologists and clinical scientists that have been supported by drug companies. Still the data supporting that factor VII should be ignored during VKA monitoring are there in peer reviewed journals, including in The Lancet Haematology 2015, Blood 2021 and Blood VTH 2025. These results have not been contested but remain ignored.
Is it possible that medical doctors prioritize convenience of prescription over effectiveness? Convenience for patients over less disability and death? How do patients and health authorities feel about that if true?”
Stay informed on the latest scientific developments in coagulation with Hemostasis Today.
-
Aug 4, 2025, 06:00Genotype–Phenotype Understanding in Hemophilia B: Commentary on Factor IX Missense Variants
-
Aug 4, 2025, 05:47National Health Center Week – Recognizing the Vital Role of HTCs in Specialized Care
-
Aug 4, 2025, 05:33Women with Hemophilia Finally Heard: “DISMISSED” Premieres August 22
-
Aug 4, 2025, 04:58Women with Inherited Bleeding Disorders: Overcoming Diagnostic and Clinical Challenge
-
Aug 4, 2025, 01:37EAHAD Launches Italian Booklet to Support Young Girls With Bleeding Disorders During Their First Period
-
Aug 4, 2025, 01:59Michael Makris Posts Haemophilia Journal Article Reassessing UK Blood Inquiry
-
Aug 4, 2025, 01:09Manuel Monreal Congratulates Authors Ahead of JTH Publication: VTE-Predict Score Validated in RIETE Cohort
-
Aug 3, 2025, 17:48Nathan Connell: What Is The "Mild Equivalent" For Hemophilia A That Is Achieved While on Emicizumab?
-
Aug 3, 2025, 03:54Cedric Hermans on the Inspiring Impact of the WFH Humanitarian Aid Program Worldwide
-
Aug 2, 2025, 20:14Sebastian Szmit Shares Patients’ Perspectives on Decision‑Making for Antithrombotic Therapy in Advanced Cancer
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Aug 4, 2025, 05:20NBCA: Alexis’s DVT Diagnosis Came Without Warning - Learn How She Caught It Early
-
Aug 4, 2025, 00:50NBCA: After Losing Her Daughter to a Blood Clot, Charita Fights to Save Others
-
Aug 3, 2025, 18:10Andrew Agwunobi Congrats Dr. Oladipo Cole and The Whole Team at the Connecticut Bleeding Disorder Center
-
Aug 3, 2025, 12:03Elias Bouchi Presents Werfen EEMEA Talks on Hemostasis: Clot Stories Season 3
-
Jul 31, 2025, 15:37Sano Genetics: “Unreasonable” Leadership with Benny Sorenson of Hemab